SG11201503215XA - Novel method for treating spinal cord injury using hmgb1 fragment - Google Patents

Novel method for treating spinal cord injury using hmgb1 fragment

Info

Publication number
SG11201503215XA
SG11201503215XA SG11201503215XA SG11201503215XA SG11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA SG 11201503215X A SG11201503215X A SG 11201503215XA
Authority
SG
Singapore
Prior art keywords
spinal cord
novel method
cord injury
treating spinal
hmgb1 fragment
Prior art date
Application number
SG11201503215XA
Other languages
English (en)
Inventor
Katsuto Tamai
Takehiko Yamazaki
Wenhao Cui
Original Assignee
Genomix Co Ltd
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomix Co Ltd, Univ Osaka filed Critical Genomix Co Ltd
Publication of SG11201503215XA publication Critical patent/SG11201503215XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201503215XA 2012-10-25 2013-10-24 Novel method for treating spinal cord injury using hmgb1 fragment SG11201503215XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012235786 2012-10-25
PCT/JP2013/078759 WO2014065348A1 (ja) 2012-10-25 2013-10-24 Hmgb1断片を利用した脊髄の損傷に対する新規治療法

Publications (1)

Publication Number Publication Date
SG11201503215XA true SG11201503215XA (en) 2015-06-29

Family

ID=50544721

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503215XA SG11201503215XA (en) 2012-10-25 2013-10-24 Novel method for treating spinal cord injury using hmgb1 fragment

Country Status (18)

Country Link
US (1) US9688733B2 (ja)
EP (1) EP2913059B1 (ja)
JP (1) JP6253590B2 (ja)
KR (1) KR102146822B1 (ja)
CN (1) CN104955470B (ja)
AU (1) AU2013335685B2 (ja)
BR (1) BR112015008745B1 (ja)
CA (1) CA2889299C (ja)
DK (1) DK2913059T3 (ja)
ES (1) ES2673861T3 (ja)
HK (2) HK1212888A1 (ja)
MX (1) MX365899B (ja)
PL (1) PL2913059T3 (ja)
RU (1) RU2649069C2 (ja)
SG (1) SG11201503215XA (ja)
TR (1) TR201807769T4 (ja)
WO (1) WO2014065348A1 (ja)
ZA (1) ZA201502829B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2284255B1 (en) 2008-04-30 2017-10-18 Genomix Co., Ltd. Method for collecting functional cells in vivo with high efficiency
ES2788394T3 (es) 2011-04-26 2020-10-21 Stemrim Inc Péptido para inducir regeneración de tejido y uso del mismo
EP2913058B1 (en) 2012-10-25 2017-12-20 Genomix Co., Ltd. Novel method for treating cardiac infarction using hmgb1 fragment
BR112019014921A2 (pt) 2017-01-27 2020-03-31 StemRIM Inc. Agente terapêutico para miocardiopatia, infarto antigo do miocárdio e insuficiência cardíaca crônica
JPWO2019107530A1 (ja) * 2017-12-01 2020-11-26 株式会社ステムリム 炎症性腸疾患の治療薬
US20210024594A1 (en) 2018-02-08 2021-01-28 StemRIM Inc. Therapeutic Agent for Psoriasis
WO2020071520A1 (ja) * 2018-10-05 2020-04-09 株式会社ステムリム 間葉系幹細胞の動員活性を有するペプチド
JP7448126B2 (ja) * 2018-10-25 2024-03-12 国立大学法人大阪大学 軟骨疾患の治療薬

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5238680B2 (ja) 1972-12-27 1977-09-30
US5658894A (en) 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5661127A (en) 1995-05-01 1997-08-26 The Regents Of The University Of California Peptide compositions with growth factor-like activity
JP3018313B2 (ja) * 1996-02-23 2000-03-13 雪印乳業株式会社 骨形成促進及び骨吸収防止剤
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
BR0012787A (pt) 1999-07-28 2002-07-30 Univ Leland Stanford Junior Agonistas de receptor de nicotina no recrutamento de célula tronco e de célula progenitora
EP1114862A3 (de) 1999-11-17 2003-08-06 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
ATE373078T1 (de) 2000-02-24 2007-09-15 Xcyte Therapies Inc Gleichzeitige stimulation und konzentration von zellen
JP3421741B2 (ja) 2000-05-18 2003-06-30 筑波大学長 人工骨髄、血球細胞の増殖方法
US20040191246A1 (en) 2003-02-26 2004-09-30 Connelly Patrick R. Process for in vivo treatment of specific biological targets in bodily fluid
ITMI20010562A1 (it) 2001-03-16 2002-09-16 Marco E Bianchi Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari
DE10121254A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag MRP8/MRP14 Heterodimers oder seiner Einzelkomponenten alleine oder in Kombination zur Behandlung und/oder Prävention von Hauterkrankungen, Wunden und/oder Wundheilungsstörungen, die durch eine verringerte Menge an MRP8/MRP14 Heterodimeren gekennzeichnet sind
EP1390058A2 (en) 2001-04-30 2004-02-25 Switch Biotech Aktiengesellschaft Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
JP2005512507A (ja) 2001-05-15 2005-05-12 ノース・ショア−ロング・アイランド・ジューイッシュ・リサーチ・インスティテュート 抗炎症剤としてのhmgフラグメントの使用
ITMI20011986A1 (it) 2001-09-25 2003-03-25 San Raffaele Centro Fond Metodo e composizione per l'attivazione di cellule presentanti l'antigene
WO2003043651A1 (en) 2001-11-19 2003-05-30 Kyowa Hakko Kogyo Co., Ltd. Drug mobilizing pluripotent stem cells from tissue into peripheral blood
KR101083454B1 (ko) 2001-12-07 2011-11-16 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법
EP1519957B1 (en) 2002-07-03 2009-03-04 Fondazione Centro San Raffaele Del Monte Tabor Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair
WO2004004770A1 (en) 2002-07-05 2004-01-15 Universite Laval Chemotactic factor inhibitor for modulating inflammatory reactions
GB0226251D0 (en) 2002-11-11 2002-12-18 San Raffaele Centro Fond Acetylated protein
EP1569684A4 (en) * 2002-11-20 2006-08-02 Critical Therapeutics Inc USE OF HMGB FRAGMENTS AS ANTI-INFLAMMATORY AGENTS
WO2004061456A2 (de) 2003-01-03 2004-07-22 Alcedo Biotech Gmbh Verwendungen von hmgb, hmgn, hmga proteinen
CA2520515C (en) 2003-03-28 2012-08-28 Universite Laval S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
US20050014255A1 (en) 2003-05-29 2005-01-20 Board Of Regents, The University Of Texas System Stem cells for clinical and commercial uses
WO2005025604A2 (en) 2003-09-10 2005-03-24 The General Hospital Corporation Use of hmgb and hmgb fragments to decrease specific immune response
ITRM20040058A1 (it) 2004-02-03 2004-05-03 Marco E Bianchi Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
EP1768693A1 (en) 2004-07-20 2007-04-04 Provincia Italiana Della Congregazione Dei Figli Dell'Immacolata Concezione - Istituto Dermopatico Dell'Immacolata Use of hmgb1 for wound healing
MX2007001155A (es) 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
AU2005279308B2 (en) 2004-09-03 2012-05-03 Creabilis Therapeutics S.R.L. Protease resistant human and non-human HMGB1 Box-A mutants and their therapeutic/diagnostic use
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 p 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
WO2006047820A1 (en) 2004-11-01 2006-05-11 Newsouth Innovations Pty Limited Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation
ITRM20050032A1 (it) 2005-01-21 2006-07-22 Marco E Bianchi Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
US9782439B2 (en) 2005-01-27 2017-10-10 Japan Health Sciences Foundation Cell sheet containing mesenchymal stem cells
CN101146559B (zh) 2005-03-23 2012-09-05 生物安全股份有限公司 用于再生医学的收集、处理和移植包括成人干细胞的细胞亚群的集成系统
WO2006114805A2 (en) 2005-04-28 2006-11-02 Fondazione Centro San Raffaele Del Monte Tabor Use of hmgb2 and hmgb3 proteins for medical applications
WO2007015546A1 (ja) 2005-08-04 2007-02-08 Genomix Co., Ltd 間葉系幹細胞誘導剤及び組織再生促進剤並びに間葉系幹細胞の調製方法
WO2007031100A1 (en) 2005-09-14 2007-03-22 Ostini, Marco Active immunotherapy of life-threatening systemic inflammation
US7829097B2 (en) 2006-02-06 2010-11-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of HMGB1 for protection against ischemia reperfusion injury
JP4982739B2 (ja) 2006-06-01 2012-07-25 国立大学法人 東京医科歯科大学 ポリグルタミン病の予防・治療剤
EP2046834B9 (en) 2006-08-11 2013-04-10 Ono Pharmaceutical Co., Ltd. Monoclonal antibodies against stromal derived factor-1 (sdf-1)
DK2055308T3 (en) 2006-10-30 2017-07-17 Genomix Co Ltd PHARMACEUTICALS FOR PROMOTING FUNCTIONAL REGENERATION OF DAMAGED TISSUE
EP2301560A4 (en) * 2008-04-30 2012-05-09 Genomix Co Ltd PHARMACEUTICAL AGENT FOR PROMOTING THE FUNCTIONAL REGENERATION OF DEGRADED TISSUE
EP2284255B1 (en) 2008-04-30 2017-10-18 Genomix Co., Ltd. Method for collecting functional cells in vivo with high efficiency
WO2009133939A1 (ja) * 2008-04-30 2009-11-05 株式会社ジェノミックス 末梢循環への骨髄由来多能性幹細胞動員薬
CA2777663A1 (en) * 2009-10-16 2011-04-21 University Of Medicine And Dentistry Of New Jersey Method for treating chronic nerve tissue injury using a cell therapy strategy
CN104825491A (zh) * 2009-10-28 2015-08-12 吉诺米克斯股份有限公司 利用骨髓间充质干细胞和/或多能干细胞的血中动员的组织再生促进剂
ES2788394T3 (es) 2011-04-26 2020-10-21 Stemrim Inc Péptido para inducir regeneración de tejido y uso del mismo
CN102443064A (zh) 2011-11-03 2012-05-09 刘誉 一种基于凝血酶活性的双靶向作用的嵌合多肽及其应用
EP2913058B1 (en) 2012-10-25 2017-12-20 Genomix Co., Ltd. Novel method for treating cardiac infarction using hmgb1 fragment

Also Published As

Publication number Publication date
ZA201502829B (en) 2020-11-25
BR112015008745B1 (pt) 2022-08-02
US20150274792A1 (en) 2015-10-01
HK1212888A1 (zh) 2016-06-24
CN104955470A (zh) 2015-09-30
EP2913059A4 (en) 2016-03-30
JP6253590B2 (ja) 2017-12-27
RU2649069C2 (ru) 2018-04-02
US9688733B2 (en) 2017-06-27
CA2889299C (en) 2023-02-14
WO2014065348A1 (ja) 2014-05-01
RU2015119523A (ru) 2016-12-20
TR201807769T4 (tr) 2018-06-21
KR20150102957A (ko) 2015-09-09
BR112015008745A2 (pt) 2017-11-21
JPWO2014065348A1 (ja) 2016-09-08
HK1213201A1 (zh) 2016-06-30
EP2913059B1 (en) 2018-04-11
AU2013335685B2 (en) 2017-10-12
ES2673861T3 (es) 2018-06-26
MX365899B (es) 2019-06-19
PL2913059T3 (pl) 2018-09-28
AU2013335685A1 (en) 2015-05-14
KR102146822B1 (ko) 2020-08-21
EP2913059A1 (en) 2015-09-02
CN104955470B (zh) 2017-06-16
MX2015005253A (es) 2015-10-29
CA2889299A1 (en) 2014-05-01
DK2913059T3 (en) 2018-06-25

Similar Documents

Publication Publication Date Title
HK1244502A1 (zh) 用於治療輻射或化學傷的方法
HK1212887A1 (zh) 利用 片段的治療心肌梗塞的新型方法
HK1213201A1 (zh) 利用了 片段的針對脊髄損傷的新型治療方法
HK1186748A1 (zh) 烴處理工藝
ZA201906339B (en) Methods for treating pruritus
IL227768A0 (en) Brain injury treatment methods
ZA201208219B (en) Method for treating wasterwater
IL225623A0 (en) Psoriasis treatment methods
EP2771505A4 (en) LAUNDRY TREATMENT APPARATUS
EP2731556A4 (en) METHODS AND APPARATUS FOR TREATING VERTEBRAL FRACTURES
SG11201505152PA (en) Method for inducing astrocytes
HUE050799T2 (hu) Berendezés szerves massza kezelésére
ZA201302579B (en) Apparatus for performing heat treatment
HK1202457A1 (en) Methods for treating parkinsons disease
EP2815014A4 (en) APPARATUS FOR TREATING LAUNDRY
EP2816126A4 (en) THERMAL TREATMENT METHOD
GB2502133B (en) Treatment or therapeutic apparatus
EP2930152A4 (en) APPARATUS FOR TREATING WATER
KR102010981B9 (ko) 수처리장치
GB201204071D0 (en) Polymer treatment method
GB201205911D0 (en) Hair treatment method
EP2838456A4 (en) DEVICE AND METHOD FOR THORN FURNACE FIXING
SG11201402604UA (en) Shipping-container-based ballast water treatment apparatus
HK1209040A1 (en) Methods for treating vestibulotoxicity
ZA201407215B (en) Method for emulsion treatment